Z. Ammari, SC. Pak, M. Ruzieh, O. Dasa, A. Tiwari, JC. Jaume, et al. (2018). Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature. Case reports in endocrinology, 2018, 4606491. https://doi.org/10.1155/2018/4606491

PubMed 29854487

[Abstract]
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.